41 – 50 of 77
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2003
-
Mark
Desmopressin in mild hemophilia A: indications, limitations, efficacy, and safety.
(
- Contribution to journal › Article
- 2002
-
Mark
The prognostic value of global haemostatic tests in the intensive care unit setting.
(
- Contribution to journal › Article
-
Mark
Von Willebrand's disease caused by compound heterozygosity for a substitution mutation (T1156M) in the D3 domain of the von Willebrand factor and a stop mutation (Q2470X).
(
- Contribution to journal › Article
- 2001
-
Mark
Platelet activation by Shiga toxin and circulatory factors as a pathogenetic mechanism in the hemolytic uremic syndrome
(
- Contribution to journal › Article
-
Mark
Clinical spectrum of hepatitis C-related liver disease and response to treatment with interferon and ribavirin in haemophilia or von Willebrand disease
(
- Contribution to journal › Article
-
Mark
No increased risk of venous thrombosis in women taking tranexamic acid
(
- Contribution to journal › Letter
-
Mark
Symposium in memory of Professor Inga Marie Nilsson
(
- Contribution to journal › Published meeting abstract
-
Mark
Normalization of haemoglobin concentration with recombinant erythropoietin has minimal effect on blood haemostasis
2001) In Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 16(2). p.9-313(
- Contribution to journal › Article
-
Mark
Ny in vitro-analys prövad: Blödningstid fortfarande bästa metod för test av den primära hemostasen
(
- Contribution to journal › Article
- 2000
-
Mark
NovoSeven in warfarin-treated patients
(
- Contribution to journal › Article